- Select a language for the TTS:
- UK English Female
- UK English Male
- US English Female
- US English Male
- Australian Female
- Australian Male
- Language selected: (auto detect) - EN
Play all audios:
ABSTRACT A slightly halophilic myxobacterial strain, SMH-27-4, was isolated from nearshore soil and shown to belong to a new myxobacterium genus based on phylogenetic analysis. This
slowly-growing myxobacterium produced the novel antibiotic depsipeptides miuraenamides A and B. Their physico-chemical properties and molecular formulas, C34H42N3O7Br and C34H42N3O7I, were
determined. Miuraenamides A exhibited potent and selective inhibition against a phytopathogenic microorganism, _Phytophthora_ sp., and moderate inhibition against some fungi and yeasts, but
was ineffective against bacteria. Both of the metabolites inhibited NADH oxidase at IC50 values of 50 μM, suggesting, like β-methoxyacrylate-type antibiotics, the electron transfer system of
the mitochondrial respiratory chain as the cellular target. SIMILAR CONTENT BEING VIEWED BY OTHERS SUERTIDES A–C: SELECTIVE ANTIBACTERIAL CYCLIC HEXAPEPTIDES FROM _AMYCOLATOPSIS_ SP.
MST-135876V3 Article Open access 26 July 2022 BISPRENYL NAPHTHOQUINONE AND CHLORINATED CALCIMYCIN CONGENER BEARING THIAZOLE RING FROM AN ACTINOMYCETE OF THE GENUS _PHYTOHABITANS_ Article 07
September 2022 A NEW STEROID WITH POTENT ANTIMICROBIAL ACTIVITIES AND TWO NEW POLYKETIDES FROM _PENICILLIUM VARIABILE_ EN-394, A FUNGUS OBTAINED FROM THE MARINE RED ALGA _RHODOMELA
CONFERVOIDES_ Article 26 October 2023 ARTICLE PDF REFERENCES * Reichenbach H, Höfle G . Production of Bioactive Secondary Metabolites. _In_: Dworkin M, Kaiser D (eds). _Myxobacteria II_.
American Society for Microbiology, Washington DC, pp. 347–397 ( 1993) Google Scholar * Reichenbach H, Gerth K, Irschik H, Kunze B, Höfle G . Myxobacteria: a source of new antibiotics.
_Trends Biotechnol_ 6: 115–121 ( 1988) Article CAS Google Scholar * Reichenbach H, Höfle G . Myxobacteria as Producers of Secondary Metabolites. _In_: Grabley S, Thiericke R (eds). _Drug
Discovery from Nature_. Springer, Berlin, pp. 149–179 ( 1999) Google Scholar * Gerth K, Pradella S, Perlova O, Beyer S, Müller R . Myxobacteria: proficient producers of novel natural
products with various biological activities—past and future biotechnological aspects with the focus on the genus _Sorangium_. _J Biotechnol_ 106: 233–253 ( 2003) Article CAS PubMed Google
Scholar * Iizuka T, Jojima Y, Fudou R, Yamanaka S . Isolation of myxobacteria from the marine environment. _FEMS Microbiol Lett_ 169: 317–322 ( 1998) Article CAS PubMed Google Scholar
* Fudou R, Iizuka T, Yamanaka S . Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 1. Fermentation and biological characteristics. _J Antibiot_ 54: 149–152 (
2001) Article CAS PubMed Google Scholar * Fudou R, Iizuka T, Sato S, Ando T, Shimba N, Yamanaka S . Haliangicin, a novel antifungal metabolite produced by a marine myxobacterium. 2.
Isolation and structural elucidation. _J Antibiot_ 54: 153–156 ( 2001) Article CAS PubMed Google Scholar * Kundim BA, Itou Y, Sakagami Y, Fudou R, Iizuka T, Yamanaka S, Ojika M . New
haliangicin isomers, potent antifungal metabolites produced by a marine myxobacterium. _J Antibiot_ 56: 630–638 ( 2003) Article CAS PubMed Google Scholar * Ojika M, Suzuki Y, Tsukamoto
A, Sakagami Y, Fudou R, Yoshimura T, Yamanaka S . Cystothiazoles A and B, new bithiazole-type antibiotics from the myxobacterium _Cystobacter fuscus_. _J Antibiot_ 51: 275–281 ( 1998)
Article CAS PubMed Google Scholar * Suzuki Y, Ojika M, Sakagami Y, Fudou R, Yamanaka S . Cystothiazoles C~F, new bithiazole-type antibiotics from the myxobacterium _Cystobacter fuscus_.
_Tetrahedron_ 54: 11399–11404 ( 1998) Article CAS Google Scholar * Akita H, Sasaki T, Kato K, Suzuki Y, Kondo K, Sakagami Y, Ojika M, Fudou R, Yamanaka S . (+)-Cystothiazole G: isolation
and structural elucidation. _Tetrahedron_ 60: 4735–4738 ( 2004) Article CAS Google Scholar * Kundim BA, Itou Y, Sakagami Y, Fudou R, Yamanaka S, Ojika M . Novel antifungal polyene amides
from the myxobacterium _Cystobacter fuscus_: isolation, antifungal activity and absolute structure determination. _Tetrahedron_ 60: 10217–10221 ( 2004) Article CAS Google Scholar *
Thierbach G, Reichenbach H . Myxothiazol, a new inhibitor of the cytochrome b-c1 segment of the respiratory chain. _Biochim Biophys Acta_ 638: 282–289 ( 1981) Article CAS PubMed Google
Scholar * Fang J, Beattie DS . External alternative NADH dehydrogenase of _Saccharomyces cervisiae_: a potential source of superoxide. _Free Radic Biol Med_ 34: 478–488 ( 2003) Article CAS
PubMed Google Scholar * Iizuka T, Jojima Y, Fudou R, Hiraishi A, Ahn J-W, Yamanaka S . _Plesiocystis pacifica_ gen. nov., sp. nov., a marine myxobacterium that contains dihydrogenated
menaquinone, isolated from the Pacific coasts of Japan. _Int J Syst Evol Microbiol_ 53: 189–195 ( 2003) Article CAS PubMed Google Scholar * Iizuka T, Jojima Y, Fudou R, Tokura M,
Hiraishi A, Yamanaka S . _Enhygromyxa salina_ gen. nov., sp. nov., a slightly halophilic myxobacterium isolated from the coastal areas of Japan. _Syst Appl Microbiol_ 26: 189–196 ( 2003)
Article PubMed Google Scholar * Sauter H, Steglich W, Anke T . Strobilurins: evolution of a new class of active substances. _Angew Chem Int Ed_ 38: 1328–1349 ( 1999) Article Google
Scholar * Sasse F, Leibold T, Kunze B, Höfle G, Reichenbach H . Cyrmenins, new β-methoxyacrylate inhibitors of the electron transport. Production, isolation, physico-chemical and biological
properties. _J Antibiot_ 56: 827–831 ( 2003) Article CAS PubMed Google Scholar * Leibold T, Sasse F, Reichenbach H, Höfle G . Cyrmenins, novel antifungal peptides containing a
nitrogen-linked β-methoxyacrylate pharmacophore: Isolation and structural elucidation. _Eur J Org Chem_ 431–435 ( 2004) Download references AUTHOR INFORMATION AUTHORS AND AFFILIATIONS *
Microbiology Group, Institute of Life Sciences, Ajinomoto Co., Inc., 1-1 Suzuki-cho, Kawasaki-ku, Kawasaki, 210-8681, Japan Takashi Iizuka, Ryosuke Fudou & Yasuko Jojima * Faculty of
Textile Science and Technology, Shinshu University, 3-15-1 Tsuneda, Ueda, 386-8567, Japan Sumie Ogawa & Shigeru Yamanaka * Graduate School of Bioagricultural Sciences, Nagoya University,
Furo-cho, Chikusa-ku, Nagoya, 464-8601, Japan Yasutaka Inukai & Makoto Ojika Authors * Takashi Iizuka View author publications You can also search for this author inPubMed Google
Scholar * Ryosuke Fudou View author publications You can also search for this author inPubMed Google Scholar * Yasuko Jojima View author publications You can also search for this author
inPubMed Google Scholar * Sumie Ogawa View author publications You can also search for this author inPubMed Google Scholar * Shigeru Yamanaka View author publications You can also search for
this author inPubMed Google Scholar * Yasutaka Inukai View author publications You can also search for this author inPubMed Google Scholar * Makoto Ojika View author publications You can
also search for this author inPubMed Google Scholar CORRESPONDING AUTHOR Correspondence to Ryosuke Fudou. RIGHTS AND PERMISSIONS Reprints and permissions ABOUT THIS ARTICLE CITE THIS ARTICLE
Iizuka, T., Fudou, R., Jojima, Y. _et al._ Miuraenamides A and B, Novel Antimicrobial Cyclic Depsipeptides from a New Slightly Halophilic Myxobacterium: Taxonomy, Production, and Biological
Properties. _J Antibiot_ 59, 385–391 (2006). https://doi.org/10.1038/ja.2006.55 Download citation * Received: 16 May 2006 * Accepted: 01 July 2006 * Issue Date: 01 July 2006 * DOI:
https://doi.org/10.1038/ja.2006.55 SHARE THIS ARTICLE Anyone you share the following link with will be able to read this content: Get shareable link Sorry, a shareable link is not currently
available for this article. Copy to clipboard Provided by the Springer Nature SharedIt content-sharing initiative KEYWORDS * myxobacterium * antibiotics * depsipeptides * polyketide *
electron transport inhibitor